id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-253609-vi2fb43t	Gopinathannair, Rakesh	COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies	2020-06-03		.txt	text/plain	3198	176	44	Sixty of 489 respondents (12.3%) reported having to discontinue therapy with HCQ + AZM due to significant QTc prolongation and 20 (4.1%) reported cases of Torsade de Pointes in patients on HCQ/chloroquine and AZM. To better understand the cardiac arrhythmic manifestations and treatment strategies employed in hospitalized COVID-19 patients through a worldwide cross-sectional survey of arrhythmia professionals. The major findings of this global survey include the following: (a) In hospitalized COVID-19 patients, EP professionals across the globe reported a wide variety of arrhythmic manifestations, with several reporting potentially life-threatening ventricular arrhythmias (sustained monomorphic VT, polymorphic VT/Torsade de Pointes, VT/VF arrest) as well as Fig. 3 Difference between US and non-US respondents regarding the percentage of hospitalized COVID-19 patients being treated with HCQ/chloroquine + azithromycin Fig. 2 Characteristics of bradyarrhythmias observed in hospitalized COVID-19 patients pulseless electrical activity.	./cache/cord-253609-vi2fb43t.txt	./txt/cord-253609-vi2fb43t.txt